To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ADIPOR2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
508 supporting clones for gene ADIPOR2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB087192 testis .a 1 to 232 2 to 233   tiling clone, capped   232/232
(100 %)
0 diff
(100 %id)
DA110318 cerebellum .a 2 to 554 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AK128511 trachea .a 5 to 4022 1 to 4018 exact tiling clone, available from FLJ,   4018/4018
(100 %)
6 diff
(99.9 %id)
DA239550 brain .a 6 to 606 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
DB218016 trachea .a 6 to 553 2 to 551   capped   550/555
(99 %)
2 diff
(99.7 %id)
DA338139 hippocampus .a 41 to 626 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA493251 brain .a 41 to 626 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA999754 breast, tumor tissue .a 43 to 565 2 to 525   capped   524/524
(100 %)
2 diff
(99.7 %id)
DA809679 brain .a 45 to 598 2 to 555   capped   554/554
(100 %)
5 diff
(99.1 %id)
DA339767 hippocampus .a 48 to 635 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA442599 tongue, tumor tissue .a 48 to 619 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BU521367 leiomyosarcoma, uterus .a 48 to 892 1 to 849       849/883
(96 %)
18 diff
(98.0 %id)
DA104710 cerebellum .a 49 to 593 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA225077 brain .a 49 to 543 2 to 496   capped   495/495
(100 %)
1 diff
(99.8 %id)
DA232334 brain .a 49 to 613 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA236953 brain .a 49 to 617 2 to 570   capped   569/570
(99 %)
1 diff
(99.9 %id)
DA239208 brain .a 49 to 614 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA311770 hippocampus .a 49 to 549 2 to 503   capped   502/505
(99 %)
2 diff
(99.7 %id)
DA313042 hippocampus .a 49 to 572 2 to 526   capped   525/525
(100 %)
2 diff
(99.7 %id)
DA336949 hippocampus .a 49 to 628 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA386869 thalamus .a 49 to 622 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA403874 thalamus .a 49 to 607 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA415741 thalamus .a 49 to 537 2 to 490   capped   489/489
(100 %)
0 diff
(100 %id)
DA755730   .a 49 to 604 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA218374 brain .a 51 to 584 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DA319387 hippocampus .a 51 to 613 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA334488 hippocampus .a 51 to 628 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA336822 hippocampus .a 51 to 412 2 to 363   capped   362/362
(100 %)
0 diff
(100 %id)
DA340401 hippocampus .a 51 to 633 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA321311 hippocampus .a 52 to 545 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DA402354 thalamus .a 53 to 610 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA417664 thalamus .a 53 to 590 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB230046 trachea .a 58 to 659 2 to 604   capped   603/603
(100 %)
1 diff
(99.9 %id)
BC051858 Uterus, leiomyosarcoma .a 59 to 1604 1 to 1546 exact tiling clone, available from MGC, AAA   1546/1546
(100 %)
1 diff
(100.0 %id)
NM_024551.2   .a 59 to 4022 1 to 3964 exact RefSeq, AAA   3964/3964
(100 %)
1 diff
(100.0 %id)
BQ439997 leiomyosarcoma, uterus .a 74 to 913 1 to 854       854/902
(94 %)
23 diff
(97.5 %id)
DA305641 hippocampus .a 169 to 464 173 to 469   capped   297/468
(63 %)
6 diff
(98.8 %id)
AY424280   .a 180 to 4015 1 to 3836 exact AAA   3836/3836
(100 %)
5 diff
(99.9 %id)
DA336722 hippocampus .a 182 to 717 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
DA395349 thalamus .a 230 to 811 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
TI_1948211954   .a 255 to 905 128 to 779   fully sequenced,   652/779
(83 %)
7 diff
(99.2 %id)
TI_1948212089   .a 255 to 827 134 to 706   fully sequenced,   573/706
(81 %)
6 diff
(99.2 %id)
TI_1948212235   .a 255 to 905 134 to 784       651/1340
(48 %)
6 diff
(99.6 %id)
TI_1948212372   .a 255 to 905 138 to 788   fully sequenced,   651/788
(82 %)
6 diff
(99.3 %id)
EL734726 mixed .a 256 to 916 1 to 661       661/661
(100 %)
0 diff
(100 %id)
DA339024 hippocampus .a 356 to 943 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA732814   .a 425 to 1182 2 to 765   capped   764/807
(94 %)
18 diff
(97.8 %id)
DA716273   .a 520 to 1094 2 to 576   capped   575/583
(98 %)
1 diff
(99.9 %id)
AK025085 colon .a 531 to 4015 1 to 3484   available from FLJ, AAA   3484/3484
(100 %)
8 diff
(99.8 %id)
FN163453 breast carcinoma .a 548 to 616 10 to 78       69/78
(88 %)
6 diff
(92.4 %id)
DA126080 cerebellum .a 665 to 1243 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA407020 thalamus .a 669 to 1205 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DB087823 testis .a 671 to 1212 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB091165 testis .a 673 to 1256 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DB133891 thymus .a 673 to 1212 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA737967   .a 681 to 1425 2 to 746   capped   745/745
(100 %)
1 diff
(99.9 %id)
DA011631 adrenal gland .a 730 to 1313 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
BG167068 hypernephroma, cell line, Kidney .a 742 to 1480 1 to 734       734/813
(90 %)
16 diff
(98.1 %id)
DA478309   .a 753 to 1303 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
TI_1948212090   .a 797 to 1415 741 to 123   fully sequenced,   619/741
(83 %)
1 diff
(99.9 %id)
EH335157   .a 848 to 910 1 to 63       63/63
(100 %)
0 diff
(100 %id)
AW296756   .a 848 to 1165 16 to 333     Submitted on the opposite strand 318/318
(100 %)
0 diff
(100 %id)
TI_1948211955   .a 875 to 1415 671 to 123   fully sequenced,   549/671
(81 %)
0 diff
(100 %id)
TI_1948212373   .a 875 to 1415 650 to 110   fully sequenced,   541/650
(83 %)
0 diff
(100 %id)
DB136059 thymus .a 891 to 1434 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB141332 thymus .a 891 to 1420 2 to 531   capped   530/530
(100 %)
2 diff
(99.7 %id)
TI_1948212236   .a 896 to 1415 648 to 129       520/1424
(36 %)
5 diff
(99.7 %id)
CA308613 Alveolar Macrophage, lung .a 896 to 1608 728 to 19   AAA   710/728
(97 %)
11 diff
(98.5 %id)
BF732341 fibrotheoma, ovary .a 945 to 1575 628 to 1   tiling clone,   628/628
(100 %)
3 diff
(99.6 %id)
CA308776 Alveolar Macrophage, lung .a 958 to 1604 664 to 19   AAA   646/646
(100 %)
3 diff
(99.6 %id)
AU253446 neuroblastoma .a 969 to 1647 18 to 700       683/700
(97 %)
17 diff
(97.6 %id)
BF767634 colon_normal .a 976 to 1359 419 to 33     Submitted on the opposite strand 387/457
(84 %)
13 diff
(97.2 %id)
DA739972   .a 1003 to 1545 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA443227 tongue, tumor tissue .a 1004 to 1579 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA453904 tongue, tumor tissue .a 1008 to 1589 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA772285 brain .a 1034 to 1591 2 to 559   capped   558/562
(99 %)
3 diff
(99.5 %id)
BQ679974 melanotic melanoma, cell line, skin .a 1145 to 1604 1 to 460   AAA   460/460
(100 %)
1 diff
(99.8 %id)
DB519691 testis .a 1153 to 1609 1 to 457     Submitted on the opposite strand 457/457
(100 %)
3 diff
(99.4 %id)
AW362755 colon .a 1205 to 1841 649 to 15       635/649
(97 %)
7 diff
(99.0 %id)
BY795920 eye .a 1275 to 1899 1 to 626       626/626
(100 %)
2 diff
(99.7 %id)
DA735823   .a 1308 to 2031 2 to 723   capped   722/722
(100 %)
4 diff
(99.5 %id)
DA735450   .a 1310 to 2126 2 to 818   capped   817/817
(100 %)
11 diff
(98.7 %id)
DA780504 brain .a 1315 to 1879 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
DA288689 corpus callosum .a 1377 to 1941 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DB166380 thyroid gland .a 1581 to 2203 2 to 625   capped   624/624
(100 %)
1 diff
(99.9 %id)
DA866011 Prostate .a 1664 to 2232 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA178987 amygdala .a 1727 to 2266 2 to 541   capped   540/540
(100 %)
4 diff
(99.3 %id)
DA286642 corpus callosum .a 1727 to 2295 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA293229 hippocampus .a 1727 to 2298 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA299656 hippocampus .a 1728 to 2304 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA825707 pericardium .a 1729 to 2298 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
FN148179 breast carcinoma .a 1868 to 1971 1 to 107       107/111
(96 %)
5 diff
(95.5 %id)
BP381353 adipose tissue .a 1904 to 2517 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BG250210 adenocarcinoma, cell line, Liver .a 1916 to 2620 1 to 704       704/949
(74 %)
16 diff
(98.4 %id)
DA148676 amygdala .a 1934 to 2480 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
TI_57244607   .a 1952 to 2709 78 to 834       757/836
(90 %)
10 diff
(98.9 %id)
BF984177 duodenal adenocarcinoma, cell line, small intestine .a 1954 to 2623 1 to 667       667/959
(69 %)
9 diff
(99.1 %id)
BG117402 adenocarcinoma, cell line, Liver .a 1954 to 2713 1 to 768       768/1077
(71 %)
33 diff
(97.0 %id)
BI917317 brain .a 1956 to 2709 1 to 752       752/754
(99 %)
9 diff
(98.9 %id)
DB497997 hypothalamus .a 1964 to 2457 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
AA182411 brain, neuroepithelial cells .a 1965 to 2461 1 to 497       497/497
(100 %)
3 diff
(99.4 %id)
DA297238 hippocampus .a 1968 to 2532 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BE409799 choriocarcinoma, placenta .a 1972 to 2600 27 to 664       638/841
(75 %)
21 diff
(97.6 %id)
BF203901 muscle, rhabdomyosarcoma .a 1973 to 2682 1 to 715       715/827
(86 %)
19 diff
(97.8 %id)
BF309750 muscle, rhabdomyosarcoma .a 1973 to 2697 1 to 721       721/722
(99 %)
11 diff
(98.5 %id)
BE798588 lung, small cell carcinoma .a 1974 to 2678 11 to 715       705/716
(98 %)
1 diff
(99.9 %id)
BI116319 lung, small cell carcinoma .a 1975 to 2745 1 to 773       773/900
(85 %)
19 diff
(97.9 %id)
CN259998 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1976 to 2707 1 to 732       732/738
(99 %)
4 diff
(99.5 %id)
AW250152 lung, small cell carcinoma .a 1976 to 2289 7 to 320       314/320
(98 %)
6 diff
(98.2 %id)
AW245768 lung, small cell carcinoma .a 1976 to 2576 7 to 607       601/607
(99 %)
11 diff
(98.2 %id)
BE267056 lung, small cell carcinoma .a 1976 to 2610 41 to 674       634/675
(93 %)
5 diff
(99.3 %id)
CD632140   .a 1977 to 2680 709 to 6       704/713
(98 %)
0 diff
(100 %id)
BF984560 duodenal adenocarcinoma, cell line, small intestine .a 1977 to 2741 1 to 758       758/956
(79 %)
20 diff
(98.0 %id)
BI868300 adenocarcinoma, cell line, Liver .a 1977 to 2649 1 to 673       673/673
(100 %)
0 diff
(100 %id)
TI_57227955   .a 1977 to 2649 23 to 695       673/673
(100 %)
0 diff
(100 %id)
BF304528 muscle, rhabdomyosarcoma .a 1978 to 2623 1 to 648       648/882
(73 %)
14 diff
(98.5 %id)
BF968359 adrenal cortex carcinoma, cell line, adrenal gland .a 1978 to 2707 1 to 728       728/729
(99 %)
9 diff
(98.8 %id)
BG034120 breast, mammary adenocarcinoma, cell line .a 1978 to 2750 1 to 763       763/809
(94 %)
18 diff
(97.8 %id)
BG424275 Kidney, renal cell adenocarcinoma .a 1978 to 2785 1 to 806       806/916
(87 %)
35 diff
(96.2 %id)
BG481382 choriocarcinoma, placenta .a 1978 to 2632 1 to 655       655/657
(99 %)
2 diff
(99.7 %id)
BG825276 muscle, rhabdomyosarcoma .a 1978 to 2709 1 to 731       731/731
(100 %)
5 diff
(99.4 %id)
DA829779 placenta .a 1978 to 2648 31 to 703   capped   673/704
(95 %)
4 diff
(99.5 %id)
CN259995 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1979 to 2671 1 to 692       692/692
(100 %)
3 diff
(99.6 %id)
BF027171 melanotic melanoma, skin .a 1979 to 2581 28 to 630       603/630
(95 %)
6 diff
(99.1 %id)
BG388753 embryonal carcinoma, cell line, testis .a 1979 to 2766 1 to 783       783/805
(97 %)
15 diff
(98.2 %id)
BM451918 eye, retinoblastoma .a 1979 to 2737 1 to 759       759/906
(83 %)
3 diff
(99.7 %id)
BQ431377 eye, retinoblastoma .a 1979 to 2781 1 to 806       806/845
(95 %)
5 diff
(99.5 %id)
DR155983 human embryonic stem cells differentiated toan early endodermal cell type .a 1979 to 2601 1 to 623       623/623
(100 %)
0 diff
(100 %id)
TI_45133634   .a 1979 to 2630 65 to 732       668/674
(99 %)
39 diff
(94.3 %id)
BE019096 muscle, rhabdomyosarcoma .a 1980 to 2504 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
BG259716 embryonal carcinoma, cell line, testis .a 1980 to 2751 1 to 767       767/957
(80 %)
24 diff
(97.5 %id)
BI225016 Burkitt lymphoma, lymph .a 1980 to 2415 1 to 437       437/437
(100 %)
3 diff
(99.4 %id)
BM051744 Burkitt lymphoma, lymph .a 1980 to 2781 1 to 804       804/814
(98 %)
8 diff
(99.1 %id)
BM051851 Burkitt lymphoma, lymph .a 1980 to 2713 1 to 734       734/741
(99 %)
14 diff
(98.2 %id)
BU169607 embryonal carcinoma, cell line, testis .a 1980 to 2809 1 to 848       848/938
(90 %)
28 diff
(97.1 %id)
BU188687 melanotic melanoma, skin .a 1980 to 2841 1 to 874       874/893
(97 %)
13 diff
(98.6 %id)
BQ431429 melanotic melanoma, skin .a 1980 to 2865 1 to 899       899/903
(99 %)
31 diff
(96.6 %id)
CB123479 Liver .a 1980 to 2549 1 to 570       570/570
(100 %)
0 diff
(100 %id)
CB163907 Liver .a 1980 to 2549 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
AA332552 Embryo, 8 weeks .a 1981 to 2426 1 to 447       447/447
(100 %)
2 diff
(99.6 %id)
AA338000 endometrium .a 1981 to 2272 1 to 292       292/292
(100 %)
0 diff
(100 %id)
CD632139   .a 1981 to 2607 8 to 633       626/633
(98 %)
6 diff
(99.1 %id)
BQ721502 sympathetic trunk .a 1981 to 2895 41 to 957       917/970
(94 %)
30 diff
(97.0 %id)
BQ717963 sympathetic trunk .a 1981 to 2739 12 to 770       759/832
(91 %)
3 diff
(99.7 %id)
BQ691909 ductal carcinoma, cell line, Pancreas .a 1981 to 2653 12 to 686       675/947
(71 %)
4 diff
(99.6 %id)
BQ652189 hepatocellular carcinoma, cell line, Liver .a 1981 to 2805 14 to 838       825/839
(98 %)
4 diff
(99.6 %id)
DR155351 human embryonic stem cells differentiated toan early endodermal cell type .a 1981 to 2713 1 to 732       732/732
(100 %)
1 diff
(99.9 %id)
CD557992 testis .a 1981 to 2848 1 to 874       874/881
(99 %)
11 diff
(98.8 %id)
TI_45133660   .a 1981 to 2794 63 to 878       816/816
(100 %)
44 diff
(94.7 %id)
TI_59382434   .a 1981 to 2541 100 to 678       579/867
(66 %)
24 diff
(97.3 %id)
CB160653 Liver .a 1981 to 2598 1 to 618       618/618
(100 %)
0 diff
(100 %id)
CR999924 T-Lymphocytes .a 1981 to 2638 1 to 660       660/662
(99 %)
7 diff
(99.0 %id)
BQ279076 adenocarcinoma, cell line, breast .a 1982 to 2848 1 to 873       873/930
(93 %)
7 diff
(99.3 %id)
BU539201 adenocarcinoma, cell line, breast .a 1982 to 2736 1 to 760       760/991
(76 %)
7 diff
(99.3 %id)
BU539616 adenocarcinoma, cell line, breast .a 1982 to 2749 1 to 773       773/915
(84 %)
14 diff
(98.5 %id)
BU943971 adenocarcinoma, cell line, breast .a 1982 to 2906 1 to 928       928/931
(99 %)
14 diff
(98.5 %id)
BQ688471 ductal carcinoma, cell line, Pancreas .a 1983 to 2842 1 to 863       863/863
(100 %)
3 diff
(99.7 %id)
BF313470 brain, neuroblastoma .a 1984 to 2661 1 to 673       673/961
(70 %)
12 diff
(98.8 %id)
BG825122 muscle, rhabdomyosarcoma .a 1984 to 2685 1 to 702       702/703
(99 %)
2 diff
(99.8 %id)
BQ224355 embryonal carcinoma, cell line, testis .a 1984 to 2841 1 to 862       862/862
(100 %)
5 diff
(99.5 %id)
BQ431856 melanotic melanoma, skin .a 1985 to 2792 12 to 824       813/835
(97 %)
13 diff
(98.5 %id)
BP422316 small intestine .a 1987 to 2506 1 to 520     Submitted on the opposite strand 520/520
(100 %)
0 diff
(100 %id)
BG034687 breast, mammary adenocarcinoma, cell line .a 1987 to 2747 1 to 761       761/962
(79 %)
25 diff
(97.5 %id)
BQ646776 hepatocellular carcinoma, cell line, Liver .a 1987 to 2939 1 to 952       952/953
(99 %)
18 diff
(98.2 %id)
BU838477 dorsal root ganglia .a 1989 to 2916 1 to 940       940/946
(99 %)
25 diff
(97.4 %id)
BM706853 eye, optic nerve .a 1991 to 2611 9 to 629       621/629
(98 %)
6 diff
(99.1 %id)
BE266793 lung, small cell carcinoma .a 1993 to 2517 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
CD632141   .a 1994 to 2578 588 to 4       585/595
(98 %)
0 diff
(100 %id)
BE547066 cervical carcinoma cell line, cervix .a 1997 to 2763 1 to 776       776/1009
(76 %)
26 diff
(97.5 %id)
BE264673 lung, small cell carcinoma .a 1998 to 2675 1 to 680       680/684
(99 %)
16 diff
(97.7 %id)
BE269480 Burkitt lymphoma, lymph .a 1998 to 2634 1 to 631       631/681
(92 %)
8 diff
(98.9 %id)
BE733679 choriocarcinoma, placenta .a 1998 to 2729 1 to 734       734/986
(74 %)
16 diff
(98.4 %id)
BE867414 adenocarcinoma, colon .a 1998 to 2767 1 to 769       769/933
(82 %)
30 diff
(96.8 %id)
BE543859 cervical carcinoma cell line, cervix .a 1999 to 2767 1 to 755       755/792
(95 %)
31 diff
(96.1 %id)
BE791176 lung, small cell carcinoma .a 1999 to 2799 1 to 814       814/901
(90 %)
27 diff
(97.1 %id)
BE900222 choriocarcinoma, placenta .a 1999 to 2639 1 to 642       642/642
(100 %)
3 diff
(99.6 %id)
BQ925405 large cell carcinoma, lung .a 1999 to 2927 1 to 931       931/936
(99 %)
11 diff
(98.9 %id)
CA390994 eye, RPE/choroid .a 2000 to 2494 1 to 495       495/495
(100 %)
0 diff
(100 %id)
BE268114 Burkitt lymphoma, lymph .a 2000 to 2571 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BE268028 Burkitt lymphoma, lymph .a 2000 to 2560 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BE270036 Burkitt lymphoma, lymph .a 2000 to 2532 1 to 533       533/533
(100 %)
0 diff
(100 %id)
BE397335 Burkitt lymphoma, lymph .a 2000 to 2661 1 to 660       660/662
(99 %)
6 diff
(99.1 %id)
BE513638 Burkitt lymphoma, lymph .a 2000 to 2706 1 to 711       711/785
(90 %)
21 diff
(97.4 %id)
BE740523 adenocarcinoma cell line, ovary .a 2000 to 2669 1 to 670       670/966
(69 %)
1 diff
(99.9 %id)
BE884204 leiomyosarcoma, uterus .a 2002 to 2732 1 to 743       743/948
(78 %)
33 diff
(96.6 %id)
BU527467 epidermoid carcinoma, cell line, lung .a 2002 to 2821 1 to 823       823/865
(95 %)
6 diff
(99.4 %id)
BE259992 brain, neuroblastoma .a 2004 to 2568 1 to 567       567/567
(100 %)
4 diff
(99.3 %id)
BE312362 brain, neuroblastoma .a 2004 to 2534 1 to 531       531/531
(100 %)
0 diff
(100 %id)
BE312641 brain, neuroblastoma .a 2005 to 2610 1 to 606       606/607
(99 %)
1 diff
(99.9 %id)
BE743378 adenocarcinoma cell line, ovary .a 2005 to 2848 1 to 839       839/856
(98 %)
24 diff
(97.2 %id)
BU151545 brain, neuroblastoma, cell line .a 2005 to 2898 1 to 904       904/907
(99 %)
16 diff
(98.3 %id)
CR613880 fetal brain .a 2007 to 4012 1 to 2006       2006/2006
(100 %)
0 diff
(100 %id)
BX420119 brain, fetal brain .a 2007 to 3030 1 to 1017       1017/1021
(99 %)
10 diff
(99.1 %id)
DA683434   .a 2007 to 2532 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA270315 caudate nucleus .a 2010 to 2570 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
BE274303 melanotic melanoma, skin .a 2010 to 2625 1 to 613       613/613
(100 %)
4 diff
(99.4 %id)
BU553189 ovary, teratocarcinoma, cell line .a 2011 to 2852 1 to 855       855/973
(87 %)
29 diff
(97.1 %id)
DA177544 amygdala .a 2012 to 2494 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
BE514134 Burkitt lymphoma, lymph .a 2015 to 2578 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
CN260001 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2048 to 2643 1 to 596       596/596
(100 %)
0 diff
(100 %id)
AW631090 2 pooled high-grade transitional celltumors, genitourinary tract .a 2061 to 2323 1 to 263       263/263
(100 %)
0 diff
(100 %id)
BP266622 thyroid .a 2065 to 2647 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP267161 thyroid .a 2065 to 2644 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
DA253518 caudate nucleus .a 2072 to 2663 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA055204 cerebellum .a 2119 to 2673 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA001097   .a 2127 to 2641 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
CN260002 embryonic stem cells, cell lines H1, H7, andH9 .a 2155 to 2821 1 to 667       667/667
(100 %)
5 diff
(99.3 %id)
BG026957 Bone, osteosarcoma, cell line .a 2186 to 2896 1 to 710       710/710
(100 %)
6 diff
(99.2 %id)
BI859881 breast, mammary adenocarcinoma, cell line .a 2188 to 2999 1 to 817       817/822
(99 %)
10 diff
(98.8 %id)
TI_57188777   .a 2188 to 2999 54 to 870       817/822
(99 %)
10 diff
(98.8 %id)
BP252092 Kidney .a 2200 to 2783 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP377380 uterus .a 2206 to 2775 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
BM460098 leiomyosarcoma, uterus .a 2235 to 3017 24 to 805       782/1115
(70 %)
17 diff
(98.5 %id)
BQ678807 melanotic melanoma, cell line, skin .a 2239 to 3066 1 to 832       832/936
(88 %)
21 diff
(97.8 %id)
BM792940 Ascites, stomach .a 2246 to 2870 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
W39747 Pancreas, pancreatic islet .a 2248 to 2636 1 to 390       390/390
(100 %)
1 diff
(99.8 %id)
BQ879269 dorsal root ganglia .a 2267 to 3182 1 to 933       933/933
(100 %)
14 diff
(98.5 %id)
BX460104 brain, fetal brain .a 2306 to 3229 1 to 923       923/923
(100 %)
7 diff
(99.3 %id)
BE742964 adenocarcinoma cell line, ovary .a 2306 to 3152 1 to 847       847/872
(97 %)
35 diff
(96.0 %id)
BG251365 adenocarcinoma, cell line, Liver .a 2311 to 2922 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
CD634215   .a 2322 to 2680 373 to 12       362/378
(95 %)
0 diff
(100 %id)
AA379254 skin .a 2329 to 2648 1 to 320       320/320
(100 %)
0 diff
(100 %id)
AA379307 skin .a 2329 to 2622 1 to 294       294/294
(100 %)
0 diff
(100 %id)
DA728340   .a 2346 to 3133 2 to 785   capped   784/785
(99 %)
8 diff
(99.0 %id)
BM471245 melanotic melanoma, skin .a 2373 to 3388 1 to 1030       1030/1030
(100 %)
37 diff
(96.5 %id)
BP273862   .a 2380 to 2939 1 to 560       560/560
(100 %)
5 diff
(99.2 %id)
BQ424730 melanotic melanoma, skin .a 2408 to 3217 1 to 814       814/831
(97 %)
9 diff
(99.0 %id)
BC004906 Muscle, rhabdomyosarcoma .a 2411 to 4015 1 to 1605   available from MGC, AAA   1605/1605
(100 %)
1 diff
(100.0 %id)
BG105090 adrenal cortex carcinoma, cell line, adrenal gland .a 2439 to 3183 1 to 751       751/974
(77 %)
21 diff
(97.9 %id)
BI198055 brain, neuroblastoma .a 2439 to 3174 1 to 746       746/752
(99 %)
35 diff
(95.4 %id)
FN078835 breast carcinoma .a 2440 to 2526 1 to 87       87/87
(100 %)
3 diff
(96.6 %id)
BM794823 Ascites, stomach .a 2447 to 3006 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
CF121288 CNCAP(3)T-225 cell line, Prostate .a 2461 to 3132 8 to 678       671/678
(98 %)
6 diff
(99.2 %id)
TI_154180308   .a 2461 to 3296 73 to 902       830/834
(99 %)
20 diff
(97.7 %id)
CF121300 CNCAP(3)T-225 cell line, Prostate .a 2462 to 3109 8 to 654       647/654
(98 %)
7 diff
(99.0 %id)
TI_154180323   .a 2462 to 3302 66 to 894       829/837
(99 %)
25 diff
(97.1 %id)
BQ721016 sympathetic trunk .a 2473 to 3266 1 to 794       794/919
(86 %)
15 diff
(98.4 %id)
BI255393 cervical carcinoma cell line, cervix .a 2504 to 3190 1 to 690       690/778
(88 %)
9 diff
(98.9 %id)
BM767390 Ascites, stomach .a 2508 to 3181 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
BM771522 Ascites, stomach .a 2508 to 2961 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BE792174 lung, small cell carcinoma .a 2510 to 3397 1 to 899       899/908
(99 %)
23 diff
(97.5 %id)
TI_154171441   .a 2510 to 3223 80 to 818       739/958
(77 %)
55 diff
(94.3 %id)
BX095601 senescent fibroblast .a 2513 to 2832 1 to 320       320/320
(100 %)
0 diff
(100 %id)
W47354 senescent fibroblast .a 2517 to 2914 1 to 398       398/398
(100 %)
0 diff
(100 %id)
BP383454   .a 2523 to 3020 1 to 498       498/498
(100 %)
3 diff
(99.4 %id)
DA727851   .a 2535 to 3269 2 to 740   capped   739/739
(100 %)
11 diff
(98.6 %id)
BF365731 nervous_tumor .a 2541 to 3050 510 to 1       510/511
(99 %)
16 diff
(96.9 %id)
BQ929074 carcinoma, cell line, Prostate .a 2557 to 3469 1 to 924       924/1008
(91 %)
34 diff
(96.7 %id)
CX781392 human embryonic stem cells .a 2558 to 3157 1 to 600       600/600
(100 %)
3 diff
(99.5 %id)
BF529579 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2575 to 3406 1 to 812       812/994
(81 %)
42 diff
(95.8 %id)
EL953968 eyeball .a 2580 to 3134 8 to 562       555/562
(98 %)
6 diff
(99.0 %id)
CU454423 epidermis .a 2582 to 3217 640 to 5     Submitted on the opposite strand 636/640
(99 %)
0 diff
(100 %id)
BM745137 Ascites, stomach .a 2610 to 2947 1 to 338       338/338
(100 %)
0 diff
(100 %id)
CX785727 human embryonic stem cells .a 2642 to 3427 1 to 786       786/786
(100 %)
1 diff
(99.9 %id)
FN063169 breast carcinoma .a 2696 to 2758 63 to 1     Submitted on the opposite strand 63/64
(98 %)
0 diff
(100 %id)
BE297864 muscle, rhabdomyosarcoma .a 2705 to 3001 1 to 293   available from MGC,   293/293
(100 %)
8 diff
(97.3 %id)
AA130738   .a 2707 to 3116 1 to 410       410/410
(100 %)
0 diff
(100 %id)
BE560962 Burkitt lymphoma, lymph .a 2707 to 3470 1 to 752       752/968
(77 %)
35 diff
(96.4 %id)
BE269548 Burkitt lymphoma, lymph .a 2708 to 3257 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
BE560252 Burkitt lymphoma, lymph .a 2708 to 3471 1 to 762       762/903
(84 %)
17 diff
(98.2 %id)
CB120388 Liver .a 2710 to 3225 1 to 516       516/516
(100 %)
3 diff
(99.5 %id)
AI908451 breast .a 2741 to 3195 454 to 1       454/454
(100 %)
2 diff
(99.6 %id)
BF970500 adrenal cortex carcinoma, cell line, adrenal gland .a 2750 to 3487 1 to 740       740/740
(100 %)
18 diff
(97.6 %id)
FN066432 breast carcinoma .a 2759 to 2848 88 to 1     Submitted on the opposite strand 88/89
(98 %)
2 diff
(97.8 %id)
TI_154170271   .a 2778 to 3295 82 to 599       518/520
(99 %)
12 diff
(97.7 %id)
CK004547 brain/CNS, Human Brain - Frontal Cortex .a 2792 to 3400 1 to 609       609/610
(99 %)
3 diff
(99.6 %id)
BM712267 eye, lens .a 2795 to 3346 1 to 552   fully sequenced,   552/552
(100 %)
1 diff
(99.9 %id)
BX452100 brain, fetal brain .a 2822 to 3703 10 to 890       881/960
(91 %)
8 diff
(99.2 %id)
BM705279 eye, RPE and Choroid .a 2830 to 3332 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
BU182991 melanotic melanoma, skin .a 2834 to 3636 12 to 822       811/913
(88 %)
18 diff
(98.1 %id)
BU156613 melanotic melanoma, skin .a 2836 to 3602 1 to 775       775/941
(82 %)
11 diff
(98.9 %id)
BG118211 adenocarcinoma, cell line, Liver .a 2839 to 3591 1 to 746       746/947
(78 %)
26 diff
(97.3 %id)
BF919623 nervous_tumor .a 2845 to 3243 400 to 1     Submitted on the opposite strand 400/400
(100 %)
12 diff
(97.0 %id)
AA121748 lung, lung carcinoma .a 2855 to 3282 1 to 437       437/441
(99 %)
11 diff
(97.6 %id)
W40181 lung .a 2867 to 3304 1 to 441       441/442
(99 %)
5 diff
(98.9 %id)
BQ328032 kidney_tumor .a 2870 to 3245 376 to 1       376/376
(100 %)
3 diff
(99.3 %id)
BX496913 Liver .a 2890 to 3497 1 to 608       608/608
(100 %)
3 diff
(99.6 %id)
AV722641 hypothalamus .a 2892 to 3516 1 to 621       621/625
(99 %)
11 diff
(98.3 %id)
BQ323302 colon_ins .a 2905 to 3033 129 to 1       129/131
(98 %)
1 diff
(99.3 %id)
BG167005 hypernephroma, cell line, Kidney .a 2910 to 3688 13 to 791       779/885
(88 %)
23 diff
(97.5 %id)
BE277614 melanotic melanoma, skin .a 2918 to 3677 28 to 785       758/801
(94 %)
11 diff
(98.7 %id)
BE386797 melanotic melanoma, skin .a 2918 to 3640 34 to 746       713/757
(94 %)
14 diff
(98.2 %id)
FN095965 breast carcinoma .a 2920 to 3024 102 to 3     Submitted on the opposite strand 100/102
(98 %)
0 diff
(100 %id)
BG478584 melanotic melanoma, skin .a 2934 to 3661 1 to 728       728/728
(100 %)
1 diff
(99.9 %id)
AA045271 heart .a 2941 to 3486 1 to 538   fully sequenced,   538/538
(100 %)
2 diff
(99.7 %id)
BI257645 cervical carcinoma cell line, cervix .a 2957 to 3874 3 to 914       912/945
(96 %)
6 diff
(99.4 %id)
TI_149285363   .a 2988 to 4015 1118 to 93   AAA   1026/1216
(84 %)
44 diff
(96.4 %id)
CN260000 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2990 to 3533 1 to 544       544/544
(100 %)
5 diff
(99.1 %id)
BP294613   .a 2996 to 3597 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
AA055331 heart .a 3013 to 3429 1 to 420       420/420
(100 %)
6 diff
(98.6 %id)
CR610048 Neuroblastoma Cot 25-normalized .a 3015 to 4013 1 to 999       999/999
(100 %)
0 diff
(100 %id)
BX333469 Neuroblastoma Cot 25-normalized .a 3015 to 3975 1 to 954       954/986
(96 %)
23 diff
(97.7 %id)
DR157658 human embryonic stem cells differentiated toan early endodermal cell type .a 3047 to 3750 1 to 704       704/704
(100 %)
2 diff
(99.8 %id)
BG469645 adenocarcinoma cell line, colon .a 3048 to 3939 1 to 888       888/892
(99 %)
19 diff
(97.9 %id)
W22446 eye, retina .a 3092 to 3552 471 to 6       466/698
(66 %)
0 diff
(100 %id)
TI_149315816   .a 3099 to 4015 996 to 87   AAA   910/998
(91 %)
13 diff
(98.7 %id)
BP319344 pericardium .a 3105 to 3687 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BF792792 adrenal cortex carcinoma, cell line, adrenal gland .a 3110 to 3875 1 to 760       760/786
(96 %)
10 diff
(98.8 %id)
BU185211 ductal carcinoma, cell line, Pancreas .a 3113 to 4015 1 to 905   AAA   905/906
(99 %)
31 diff
(96.6 %id)
BQ686648 ductal carcinoma, cell line, Pancreas .a 3113 to 3936 1 to 830       830/979
(84 %)
14 diff
(98.6 %id)
TI_154107701   .a 3134 to 4022 952 to 72   AAA   881/969
(90 %)
16 diff
(98.4 %id)
AV646219 corresponding non cancerous liver tissue .a 3144 to 3552 1 to 409     Submitted on the opposite strand 409/409
(100 %)
0 diff
(100 %id)
DR159225 human embryonic stem cells differentiated toan early endodermal cell type .a 3145 to 3917 1 to 773       773/773
(100 %)
1 diff
(99.9 %id)
BG469814 adenocarcinoma cell line, colon .a 3147 to 3961 1 to 815       815/816
(99 %)
3 diff
(99.7 %id)
BE004354 breast_normal .a 3169 to 3387 225 to 7     Submitted on the opposite strand 219/238
(92 %)
0 diff
(100 %id)
FN170288 breast carcinoma .a 3181 to 3266 1 to 85       85/85
(100 %)
4 diff
(95.3 %id)
TI_149303270   .a 3187 to 4015 897 to 77   AAA   821/959
(85 %)
14 diff
(98.6 %id)
BM014304 breast, mammary adenocarcinoma, cell line .a 3189 to 3868 1 to 683       683/684
(99 %)
15 diff
(97.9 %id)
TI_59392303   .a 3189 to 3868 96 to 778       683/684
(99 %)
15 diff
(97.9 %id)
CF453619 peripheral nervous system .a 3190 to 3965 1 to 775       775/775
(100 %)
3 diff
(99.7 %id)
CF453557 peripheral nervous system .a 3190 to 3930 1 to 741       741/745
(99 %)
3 diff
(99.6 %id)
CF453517 peripheral nervous system .a 3190 to 3923 1 to 734       734/734
(100 %)
2 diff
(99.8 %id)
TI_149307170   .a 3191 to 4022 912 to 88   AAA   825/951
(86 %)
9 diff
(99.1 %id)
BM876613 insulinoma, Pancreas .a 3195 to 3580 3 to 388   fully sequenced,   386/388
(99 %)
3 diff
(99.3 %id)
TI_159712087   .a 3219 to 4012 880 to 95   AAA   786/982
(80 %)
0 diff
(100 %id)
BM797998 Ascites, stomach .a 3223 to 3630 1 to 408       408/408
(100 %)
0 diff
(100 %id)
TI_149309015   .a 3228 to 4015 876 to 88   AAA   789/987
(79 %)
4 diff
(99.6 %id)
BX454889 brain, fetal brain .a 3236 to 4013 788 to 1       788/898
(87 %)
53 diff
(94.1 %id)
BU186518 large cell carcinoma, lung .a 3237 to 3927 1 to 696       696/872
(79 %)
9 diff
(99.0 %id)
CR591974 Neuroblastoma Cot 25-normalized .a 3239 to 4004 1 to 766       766/766
(100 %)
0 diff
(100 %id)
AL523234 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 3239 to 4018 1 to 780       780/780
(100 %)
6 diff
(99.3 %id)
BM981310 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3242 to 4015 790 to 19   AAA   772/773
(99 %)
5 diff
(99.4 %id)
BU188378 melanotic melanoma, skin .a 3246 to 4015 1 to 770   AAA   770/770
(100 %)
0 diff
(100 %id)
BE843828 testis_normal .a 3247 to 3526 282 to 4       279/282
(98 %)
0 diff
(100 %id)
BE843833 testis_normal .a 3247 to 3539 300 to 9       292/300
(97 %)
0 diff
(100 %id)
BE938459 testis_normal .a 3247 to 3536 301 to 12       290/301
(96 %)
0 diff
(100 %id)
BE938461 testis_normal .a 3247 to 3486 241 to 1       241/241
(100 %)
8 diff
(96.7 %id)
BE938500 testis_normal .a 3247 to 3516 271 to 3       269/271
(99 %)
0 diff
(100 %id)
BG106897 lymph, lymphoma, cell line .a 3248 to 4003 1 to 755       755/927
(81 %)
21 diff
(97.8 %id)
BG611908 adenocarcinoma, Prostate .a 3252 to 4004 1 to 751       751/755
(99 %)
12 diff
(98.5 %id)
CA447149 Chondrosarcoma, Left Pelvis .a 3255 to 4022 786 to 19   AAA   768/768
(100 %)
2 diff
(99.8 %id)
CB306500 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3256 to 4015 778 to 19   AAA   760/760
(100 %)
3 diff
(99.7 %id)
TI_154123773   .a 3258 to 4015 846 to 93   AAA   754/959
(78 %)
14 diff
(98.6 %id)
BX413482 brain, fetal brain .a 3260 to 4004 755 to 8       748/930
(80 %)
0 diff
(100 %id)
CA307006 Alveolar Macrophage, lung .a 3267 to 4015 767 to 19   AAA   749/749
(100 %)
0 diff
(100 %id)
BE548489 cervical carcinoma cell line, cervix .a 3280 to 4012 1 to 723       723/897
(80 %)
14 diff
(98.5 %id)
BU629483 cell lines, Chondrosarcoma .a 3282 to 4015 749 to 19   AAA   731/733
(99 %)
3 diff
(99.6 %id)
FN117583 breast carcinoma .a 3301 to 3399 99 to 1     Submitted on the opposite strand 99/104
(95 %)
0 diff
(100 %id)
BU737734 eye, lens .a 3316 to 4015 719 to 19   fully sequenced, AAA   701/701
(100 %)
2 diff
(99.8 %id)
BM794028 Ascites, stomach .a 3322 to 3762 1 to 442       442/442
(100 %)
2 diff
(99.6 %id)
TI_154100419   .a 3322 to 4013 779 to 88   AAA   692/694
(99 %)
0 diff
(100 %id)
BM695196 eye, optic nerve .a 3324 to 3636 1 to 314   fully sequenced,   314/314
(100 %)
0 diff
(100 %id)
AU253447 neuroblastoma .a 3326 to 4018 700 to 9       692/700
(98 %)
0 diff
(100 %id)
BU680807 lung .a 3326 to 4015 709 to 19   AAA   691/691
(100 %)
2 diff
(99.8 %id)
BU620310 Cell Line, Chondrosarcoma .a 3328 to 4015 704 to 19   AAA   686/686
(100 %)
2 diff
(99.8 %id)
TI_149291063   .a 3330 to 4022 772 to 80   tiling clone, AAA   693/693
(100 %)
0 diff
(100 %id)
H22082 breast .a 3332 to 3682 7 to 359   fully sequenced,   353/359
(98 %)
10 diff
(97.3 %id)
BU687452 lung .a 3332 to 4015 703 to 19   AAA   685/685
(100 %)
1 diff
(99.9 %id)
BQ003540 Chondrosarcoma, Left Pelvis .a 3339 to 4019 703 to 22   AAA   682/685
(99 %)
0 diff
(100 %id)
BM997430 lung, Metastatic Chondrosarcoma .a 3340 to 4015 694 to 19   AAA   676/676
(100 %)
1 diff
(99.9 %id)
CA441382 Fibrosarcoma .a 3343 to 4013 691 to 21   AAA   671/673
(99 %)
0 diff
(100 %id)
CN259997 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3356 to 4022 1 to 667   AAA   667/667
(100 %)
0 diff
(100 %id)
BM973815 lung .a 3356 to 4022 685 to 19   AAA   667/672
(99 %)
0 diff
(100 %id)
BI334744 cervical carcinoma cell line, cervix .a 3362 to 4024 14 to 678       665/711
(93 %)
4 diff
(99.5 %id)
CA431967 Alveolar Macrophage, lung .a 3373 to 4015 656 to 14   AAA   643/643
(100 %)
1 diff
(99.9 %id)
BQ694623 adipose .a 3382 to 4013 624 to 1     Submitted on the opposite strand 624/626
(99 %)
13 diff
(98.0 %id)
BQ021362 lung, Metastatic Chondrosarcoma .a 3383 to 4015 657 to 25   AAA   633/633
(100 %)
2 diff
(99.7 %id)
BQ005956 Chondrosarcoma, Left Pelvis .a 3385 to 4015 649 to 19   AAA   631/631
(100 %)
0 diff
(100 %id)
BM979080 lung, Primary Lung Epithelial Cells .a 3385 to 4022 656 to 19   AAA   638/638
(100 %)
1 diff
(99.9 %id)
CB852200 Human Lung Epithelial cells, lung .a 3385 to 4012 649 to 22   AAA   628/631
(99 %)
0 diff
(100 %id)
CA430611 Cell Line, Chondrosarcoma .a 3385 to 4022 658 to 19   AAA   640/640
(100 %)
2 diff
(99.7 %id)
BQ007901 Chondrosarcoma, Left Pelvis .a 3386 to 4022 655 to 19   AAA   637/637
(100 %)
0 diff
(100 %id)
AI904557 breast .a 3388 to 3825 435 to 1       435/460
(94 %)
8 diff
(98.3 %id)
FN080236 breast carcinoma .a 3402 to 3486 84 to 1     Submitted on the opposite strand 84/84
(100 %)
2 diff
(97.7 %id)
AV701666 adrenal gland .a 3404 to 4015 1 to 612   AAA   612/612
(100 %)
7 diff
(98.9 %id)
BU734155 eye, Retina Foveal and Macular .a 3433 to 4015 601 to 19   AAA   583/583
(100 %)
5 diff
(99.2 %id)
AL041072 testis .a 3439 to 3806 1 to 368       368/368
(100 %)
2 diff
(99.5 %id)
AA164450   .a 3447 to 3737 1 to 292   fully sequenced,   292/292
(100 %)
2 diff
(99.4 %id)
TI_151770639   .a 3447 to 4015 119 to 688   AAA   570/688
(82 %)
7 diff
(99.0 %id)
DB382388 thyroid gland .a 3452 to 4015 563 to 1       563/579
(97 %)
15 diff
(97.5 %id)
BY995549   .a 3453 to 4022 628 to 59   AAA Submitted on the opposite strand 570/570
(100 %)
1 diff
(99.9 %id)
AA045263 heart .a 3456 to 4015 555 to 1   fully sequenced,   555/555
(100 %)
1 diff
(99.9 %id)
DB349229 trachea .a 3463 to 4022 560 to 1       560/561
(99 %)
0 diff
(100 %id)
DB368167   .a 3465 to 4015 544 to 1       544/548
(99 %)
15 diff
(97.3 %id)
DB308224 hippocampus .a 3469 to 4015 547 to 1       547/547
(100 %)
0 diff
(100 %id)
DB322775   .a 3475 to 4015 541 to 1       541/542
(99 %)
0 diff
(100 %id)
DB367741   .a 3475 to 4015 539 to 1       539/544
(99 %)
12 diff
(97.8 %id)
BU734916 eye, lens .a 3477 to 4022 557 to 12   AAA   546/546
(100 %)
0 diff
(100 %id)
BG654577 Pancreas, Purified pancreatic islet .a 3488 to 4014 527 to 1     Submitted on the opposite strand 527/527
(100 %)
0 diff
(100 %id)
BF197223 brain, glioblastoma (pooled) .a 3488 to 4010 523 to 1       523/523
(100 %)
0 diff
(100 %id)
BU736841 eye, RPE and Choroid .a 3489 to 4015 545 to 19   AAA   527/527
(100 %)
0 diff
(100 %id)
CN259999 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3496 to 4018 1 to 523       523/525
(99 %)
1 diff
(99.9 %id)
N98338 lung .a 3501 to 4018 509 to 4       506/509
(99 %)
0 diff
(100 %id)
AL045495 testis .a 3508 to 4022 1 to 515   AAA   515/515
(100 %)
0 diff
(100 %id)
CA415710 Chondrosarcoma Cell line .a 3508 to 4015 526 to 19   AAA   508/508
(100 %)
0 diff
(100 %id)
AW029527 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3512 to 4015 505 to 1       505/505
(100 %)
1 diff
(99.9 %id)
AI339454 pooled germ cell tumors .a 3520 to 4017 498 to 1       498/498
(100 %)
0 diff
(100 %id)
BE205856 muscle, rhabdomyosarcoma .a 3523 to 4017 495 to 1       495/495
(100 %)
0 diff
(100 %id)
AW250913 lung, small cell carcinoma .a 3526 to 4012 500 to 14   AAA   487/490
(99 %)
0 diff
(100 %id)
CB164484 Liver .a 3526 to 4015 511 to 22   AAA Submitted on the opposite strand 490/490
(100 %)
6 diff
(98.8 %id)
BE300753 Burkitt lymphoma, lymph .a 3528 to 4017 490 to 1       490/490
(100 %)
0 diff
(100 %id)
DB370584   .a 3532 to 4015 481 to 1       481/481
(100 %)
3 diff
(99.4 %id)
AI191930   .a 3542 to 4015 485 to 12   AAA   474/474
(100 %)
0 diff
(100 %id)
AI921045 adenocarcinoma, Pancreas .a 3542 to 4015 474 to 1       474/474
(100 %)
0 diff
(100 %id)
AW299297 Kidney .a 3542 to 4017 476 to 1       476/476
(100 %)
3 diff
(99.4 %id)
BE300927 Burkitt lymphoma, lymph .a 3542 to 4017 476 to 1       476/476
(100 %)
5 diff
(99.0 %id)
BF109667 pooled .a 3542 to 4018 483 to 5       479/483
(99 %)
0 diff
(100 %id)
AI829022 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 3546 to 4015 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AW316673 brain, three pooled meningiomas .a 3548 to 4010 482 to 20   AAA   463/468
(98 %)
0 diff
(100 %id)
AW614753 colon, moderately-differentiated adenocarcinoma .a 3548 to 4015 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
AW778845 colon, moderately-differentiated adenocarcinoma .a 3548 to 4018 471 to 1       471/471
(100 %)
0 diff
(100 %id)
BF589059 sciatic nerve .a 3548 to 4023 482 to 7       476/482
(98 %)
0 diff
(100 %id)
AA130635   .a 3550 to 4016 466 to 1       466/466
(100 %)
3 diff
(99.4 %id)
BM876351 insulinoma, Pancreas .a 3550 to 4022 489 to 17   fully sequenced, AAA   473/473
(100 %)
0 diff
(100 %id)
AI610883 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3551 to 4016 466 to 1       466/466
(100 %)
0 diff
(100 %id)
BU728182 eye, optic nerve .a 3552 to 4015 482 to 19   AAA   464/464
(100 %)
2 diff
(99.6 %id)
DB569094 hypothalamus .a 3555 to 4020 1 to 466     Submitted on the opposite strand 466/468
(99 %)
1 diff
(99.8 %id)
AA918812 Kidney .a 3555 to 4015 460 to 1       460/460
(100 %)
4 diff
(99.2 %id)
AI445051 colon, moderately-differentiated adenocarcinoma .a 3555 to 4018 464 to 1       464/464
(100 %)
0 diff
(100 %id)
EC507001 Prostate .a 3559 to 3653 14 to 108       95/108
(87 %)
6 diff
(94.5 %id)
BG282255 melanotic melanoma, skin .a 3560 to 4012 1 to 455   AAA   455/459
(99 %)
5 diff
(99.0 %id)
AA303910 aorta .a 3562 to 3923 1 to 365       365/365
(100 %)
3 diff
(99.2 %id)
AA678957   .a 3563 to 4023 461 to 2       460/461
(99 %)
0 diff
(100 %id)
AA126324   .a 3566 to 4017 451 to 1       451/451
(100 %)
4 diff
(99.2 %id)
AW245410 lung, small cell carcinoma .a 3577 to 4015 450 to 12   AAA   439/440
(99 %)
0 diff
(100 %id)
AW627774 2 pooled high-grade transitional celltumors, genitourinary tract .a 3600 to 4022 423 to 1       423/423
(100 %)
2 diff
(99.6 %id)
AI886004 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3601 to 4023 428 to 5       424/428
(99 %)
0 diff
(100 %id)
BU852833 testis .a 3602 to 4010 1 to 409       409/410
(99 %)
2 diff
(99.6 %id)
F24695 pectoral muscle (after mastectomy) .a 3605 to 3962 1 to 357       357/357
(100 %)
2 diff
(99.5 %id)
DB562885 hypothalamus .a 3606 to 4020 1 to 415     Submitted on the opposite strand 415/417
(99 %)
1 diff
(99.8 %id)
BM666372 eye, optic nerve .a 3606 to 4015 427 to 19   fully sequenced, AAA   409/409
(100 %)
0 diff
(100 %id)
DB364449   .a 3610 to 4015 406 to 1       406/408
(99 %)
1 diff
(99.8 %id)
BF109098 pooled .a 3612 to 4015 419 to 16   AAA   404/404
(100 %)
1 diff
(99.8 %id)
BM711830 eye, human retina .a 3617 to 4015 1 to 399   fully sequenced, AAA   399/399
(100 %)
0 diff
(100 %id)
AA588196 normal prostate, Prostate .a 3618 to 4023 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AA508005 Prostate .a 3619 to 4015 401 to 7       395/401
(98 %)
0 diff
(100 %id)
W47355 senescent fibroblast .a 3622 to 4015 395 to 1       395/395
(100 %)
5 diff
(98.8 %id)
AA055928 heart .a 3623 to 4022 400 to 1       400/400
(100 %)
4 diff
(99.0 %id)
BF088805 head_neck .a 3624 to 3984 359 to 1       359/363
(98 %)
1 diff
(99.8 %id)
BQ353729 head_neck .a 3624 to 3887 278 to 9       270/281
(96 %)
0 diff
(100 %id)
N50400 multiple sclerosis lesions .a 3627 to 3817 1 to 191   fully sequenced,   191/191
(100 %)
2 diff
(99.0 %id)
AA984502 schizophrenic brain S-11 frontal lobe .a 3628 to 4000 372 to 1       372/372
(100 %)
1 diff
(99.8 %id)
AA480644 colon .a 3632 to 4015 396 to 13   AAA   384/384
(100 %)
0 diff
(100 %id)
AA729341 pooled germ cell tumors .a 3640 to 4016 376 to 1       376/376
(100 %)
1 diff
(99.8 %id)
BF748977 breast_normal .a 3641 to 3859 217 to 1     Submitted on the opposite strand 217/217
(100 %)
2 diff
(99.1 %id)
AA721026 germinal center B cell .a 3642 to 4022 391 to 11   AAA   381/381
(100 %)
0 diff
(100 %id)
AA121694 lung, lung carcinoma .a 3643 to 4015 395 to 23   AAA   373/373
(100 %)
2 diff
(99.5 %id)
AA779147 liver and spleen .a 3644 to 3992 350 to 1       350/350
(100 %)
3 diff
(99.2 %id)
AA570274 colon, colon tumor RER+ .a 3646 to 4016 370 to 1       370/370
(100 %)
1 diff
(99.8 %id)
H22010 breast .a 3652 to 3998 351 to 1   fully sequenced,   351/351
(100 %)
6 diff
(98.3 %id)
AA926791 pooled germ cell tumors .a 3664 to 4016 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
AA628284   .a 3666 to 4015 349 to 1       349/349
(100 %)
1 diff
(99.8 %id)
AI001861 pooled germ cell tumors .a 3668 to 4023 357 to 2       356/357
(99 %)
0 diff
(100 %id)
BE935518 marrow .a 3669 to 3805 1 to 138       138/138
(100 %)
17 diff
(87.7 %id)
AI282693 colon, moderately-differentiated adenocarcinoma .a 3670 to 4015 346 to 1       346/346
(100 %)
0 diff
(100 %id)
AW243796 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3671 to 4015 345 to 1       345/345
(100 %)
0 diff
(100 %id)
BE935393 marrow .a 3675 to 3992 319 to 1       319/324
(98 %)
20 diff
(93.9 %id)
BE935506 marrow .a 3675 to 3979 310 to 3       308/324
(95 %)
0 diff
(100 %id)
BI494027 cochlea, ear .a 3678 to 4015 1 to 338   AAA   338/338
(100 %)
4 diff
(98.9 %id)
FN098074 breast carcinoma .a 3679 to 3761 83 to 1     Submitted on the opposite strand 83/87
(95 %)
0 diff
(100 %id)
BE935311 marrow .a 3685 to 3987 306 to 4       303/306
(99 %)
0 diff
(100 %id)
BE935477 marrow .a 3685 to 3987 306 to 4       303/306
(99 %)
0 diff
(100 %id)
AA736587 germinal center B cell .a 3692 to 3957 265 to 1       265/265
(100 %)
1 diff
(99.7 %id)
W45213 Pancreas, pancreatic islet .a 3700 to 4017 320 to 1       320/320
(100 %)
2 diff
(99.4 %id)
AA164451   .a 3707 to 4015 325 to 19   fully sequenced, AAA   307/307
(100 %)
2 diff
(99.4 %id)
EH345735   .a 3710 to 3778 1 to 69       69/69
(100 %)
0 diff
(100 %id)
AA226937 brain, neuroepithelial cells .a 3715 to 3988 273 to 1       273/273
(100 %)
1 diff
(99.7 %id)
AI205733   .a 3722 to 4018 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AI039526   .a 3733 to 4023 294 to 5       290/294
(98 %)
0 diff
(100 %id)
D29599   .a 3735 to 3997 1 to 281       281/281
(100 %)
20 diff
(92.9 %id)
AI270434 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3742 to 4018 281 to 5       277/281
(98 %)
0 diff
(100 %id)
AI824525 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3742 to 4023 282 to 1       282/282
(100 %)
1 diff
(99.7 %id)
FN053209 breast carcinoma .a 3753 to 3859 106 to 1     Submitted on the opposite strand 106/107
(99 %)
1 diff
(99.1 %id)
AA627494 colon, colon tumor RER+ .a 3768 to 3878 111 to 1       111/111
(100 %)
1 diff
(99.1 %id)
BF507534   .a 3771 to 3914 1 to 143   AAA Submitted on the opposite strand 143/153
(93 %)
4 diff
(97.4 %id)
CA312980 Human Lung Epithelial cells, lung .a 3771 to 4015 1 to 246   AAA Submitted on the opposite strand 246/246
(100 %)
4 diff
(98.4 %id)
AA374731 lung .a 3782 to 3996 215 to 1     Submitted on the opposite strand 215/215
(100 %)
0 diff
(100 %id)
N51671 multiple sclerosis lesions .a 3787 to 4022 237 to 1   fully sequenced,   237/237
(100 %)
1 diff
(99.6 %id)
AA181602 brain, neuroepithelial cells .a 3789 to 4003 214 to 1       214/214
(100 %)
1 diff
(99.6 %id)
BM665642 eye, human retina .a 3800 to 4015 234 to 19   fully sequenced, AAA   216/216
(100 %)
0 diff
(100 %id)
DB374705 placenta .a 3812 to 4015 202 to 1       202/202
(100 %)
6 diff
(97.1 %id)
AI869808 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3831 to 4018 188 to 1       188/188
(100 %)
0 diff
(100 %id)
D45719 lung .a 3910 to 4018 1 to 108     Submitted on the opposite strand 108/108
(100 %)
1 diff
(99.1 %id)
AA568645 colon, colon tumor RER+ .a 3925 to 4015 91 to 1       91/91
(100 %)
0 diff
(100 %id)
AA971204 Kidney, kidney tumor .a 3934 to 4018 91 to 7       85/91
(93 %)
0 diff
(100 %id)
DB041992 testis .b 1 to 581 2 to 582   tiling clone, capped   581/581
(100 %)
0 diff
(100 %id)
DA798465 brain .b 15 to 513 2 to 500   capped   499/499
(100 %)
1 diff
(99.8 %id)
DA414529 thalamus .b 20 to 589 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA794984 brain .b 28 to 589 2 to 562   capped   561/570
(98 %)
2 diff
(99.7 %id)
DA857634 placenta .b 43 to 587 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA754448   .b 47 to 382 2 to 337   capped   336/336
(100 %)
1 diff
(99.8 %id)
CX163511 human embryonic stem cells differentiated toan early endodermal cell type .b 74 to 876 1 to 803   tiling clone,   803/803
(100 %)
1 diff
(99.9 %id)
DA407812 thalamus .b 82 to 631 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA187542 amygdala .b 84 to 617 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA327533 hippocampus .b 84 to 635 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
DA328402 hippocampus .b 84 to 647 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA334741 hippocampus .b 84 to 675 2 to 595   capped   594/594
(100 %)
3 diff
(99.5 %id)
DB284480 uterus .b 84 to 630 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA398238 thalamus .b 85 to 656 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA894489 skeletal muscle .b 89 to 654 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA102185 cerebellum .b 90 to 676 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA221569 brain .b 90 to 625 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA247561 brain .b 90 to 672 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA275036 corpus callosum .b 90 to 651 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA300517 hippocampus .b 90 to 677 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DA322123 hippocampus .b 90 to 677 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA336130 hippocampus .b 90 to 666 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA336191 hippocampus .b 90 to 690 2 to 603   capped   602/602
(100 %)
1 diff
(99.9 %id)
DA336470 hippocampus .b 90 to 670 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DA413105 thalamus .b 90 to 553 2 to 465   capped   464/464
(100 %)
1 diff
(99.8 %id)
DA754556   .b 90 to 563 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
DA760030   .b 90 to 380 2 to 292   capped   291/292
(99 %)
4 diff
(98.7 %id)
DA804991 brain .b 90 to 594 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
DA995420 synovial membrane tissue from rheumatioidarthritis .b 90 to 662 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB292363 uterus .b 90 to 672 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA249736 brain .b 92 to 667 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA323014 hippocampus .b 92 to 624 2 to 537   capped   536/536
(100 %)
3 diff
(99.5 %id)
DA331689 hippocampus .b 92 to 684 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA332444 hippocampus .b 92 to 682 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA334508 hippocampus .b 92 to 662 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA334981 hippocampus .b 92 to 618 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DA357548 subthalamic nucleus .b 92 to 648 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA406376 thalamus .b 92 to 663 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB005983 breast, tumor tissue .b 92 to 629 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB238895 trachea .b 92 to 673 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DB247317 uterus .b 92 to 618 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DB279310 uterus .b 92 to 661 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DB154765 thymus .b 99 to 676 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BI561807 testis .b 153 to 968 6 to 810 L9X C11A S12A R13G T14L ... tiling clone,   806/943
(85 %)
37 diff
(96.1 %id)
TI_44350058   .b 153 to 968 119 to 923 L9X C11A S12A R13G T14L ...     806/1056
(76 %)
37 diff
(96.5 %id)
DR005259 Prostate .b 157 to 854 8 to 705       698/706
(98 %)
7 diff
(99.1 %id)
DA320653 hippocampus .b 202 to 694 2 to 494   capped   493/493
(100 %)
0 diff
(100 %id)
DA338501 hippocampus .c 1 to 584 2 to 585   tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
BM453101 leiomyosarcoma, uterus .c 11 to 889 1 to 884 G155R R169S N171K I172Y S173L ... tiling clone,   884/1033
(85 %)
11 diff
(99.0 %id)
DB454253 testis .d 1 to 484 1 to 484   tiling clone,   484/484
(100 %)
1 diff
(99.8 %id)
CR744354 germinal center B cell .d 483 to 1275 1 to 795   tiling clone,   795/795
(100 %)
2 diff
(99.8 %id)
AA459241 germinal center B cell .d 483 to 867 1 to 385       385/385
(100 %)
0 diff
(100 %id)
BG427479 Kidney .d 679 to 1356 1 to 683   tiling clone,   683/827
(82 %)
20 diff
(97.6 %id)
AI382070 pooled .d 1180 to 1685 506 to 1   tiling clone,   506/506
(100 %)
0 diff
(100 %id)
AA459014 germinal center B cell .d 1353 to 1685 333 to 1       333/335
(99 %)
0 diff
(100 %id)
BM921518 pooled brain, lung, testis .e 1 to 789 1 to 792 N148H I149H W150L T151D H152T ... tiling clone,   792/1008
(78 %)
5 diff
(99.6 %id)
DA407734 thalamus .f 1 to 532 8 to 540 exact tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
CR745731 pooled germ cell tumors .g 1 to 393 1 to 396   tiling clone,   396/396
(100 %)
8 diff
(98.0 %id)
DA212771 brain .g 162 to 648 2 to 488 C81X R94C tiling clone, capped   487/487
(100 %)
1 diff
(99.8 %id)
DA246140 brain .h-u 1 to 535 2 to 536 exact tiling clone, capped   535/535
(100 %)
0 diff
(100 %id)
DA228265 brain .i 1 to 568 2 to 569 exact tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
AW468839 pooled .j 1 to 478 480 to 3 exact tiling clone,   478/480
(99 %)
0 diff
(100 %id)
DA407688 thalamus .k-u 1 to 557 2 to 559   tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
DA627179 Kidney .k-u 147 to 687 2 to 542 exact tiling clone, capped   541/541
(100 %)
2 diff
(99.7 %id)
AW176809 colon .k-u 541 to 882 1 to 342 R21T F22L G25W K26Q C27M ... tiling clone,   342/344
(99 %)
9 diff
(97.4 %id)
DB229122 trachea .l 1 to 597 2 to 599 exact tiling clone, capped   598/598
(100 %)
2 diff
(99.7 %id)
DA322077 hippocampus .l 7 to 534 2 to 530   tiling clone, capped   529/529
(100 %)
2 diff
(99.7 %id)
DA106733 cerebellum .m 1 to 545 2 to 546 exact tiling clone, capped   545/545
(100 %)
0 diff
(100 %id)
AK127111 brain Gene ADIPOR2, variant not shown       available from FLJ, This clone was ignored    
AK127196 hippocampus Gene ADIPOR2, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k-u, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI